Pregnant rats were treated for five consecutive days during gestation with s.c. injections of the ornithine decarboxylase (ODC) inhibitor alpha-difluoromethylornithine (DFMO). Treatment beginning at gestational days 13 or 14 was effective in inhibiting ODC and altering polyamine levels, and resulted in relatively small decreases in body and forebrain weight, but not in significant differences in adult neurochemistry. Neonatal rats were treated with DFMO from postnatal day 0 (PD 0) to PD 24. In addition to some somatic effects (decreased body weight, delayed eyelid opening and delayed fur growth) the postnatal treatment resulted in a permanent decrease in brain weight, which was mainly due to a dramatic decrease in cerebellar size. During treatment, and 3 days after the end of it, the levels of putrescine and spermidine, but not those of spermine, were consistently lower in the cerebellum and forebrain of DFMO-treated rats than in controls. On the other hand, ODC appeared strongly inhibited only during the first phase of the treatment and showed recovery, and also rebound of the activity, during the second part of the treatment. A screening of neurochemical markers related to cholinergic, GABAergic and glutamatergic neurons, as well to astrocytes and oligodendrocytes was performed in several brain regions (cerebellum, olfactory bulbs, cortex, striaturn, hippocampus) of some of these rats once they became adults. Significant alterations for all the parameters tested, with the exception of the marker for the glutamatergic transmission, were measured in the undersized cerebellum of the neonatally DFMO-treated rats. A shorter neonatal treatment with DFMO (from PD 1 to 6) resulted, in the adult, in decreased cerebellar size and in neurochemical alterations, both very similar to those occurring after the prolonged treatment. In the other brain regions a few minor differences were noticed. The present results show that: (1) the brain polyamine system is differently regulated in foetuses with respect to newborns; (2) the effects of chronic ODC blockade are different on prenatally or postnatally proliferating neurons, due either to a lower sensitivity of gestation ally proliferating neurons or to a subsequent recovery; and (3) chronic postnatal ODC inhibition has a strong effect on proliferating neurons, but little effect on further maturation of postmitotic neurons.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Bartolomé J, Schweitzer L, Slotkin TA, Nadler JV (1985) Impaired development of cerebellar cortex in rats treated postnatally with alpha-difluoromethylornithine. Neuroscience 15:203–213
Baudry M, Lynch G, Gall C (1986) Induction of ornithine decarboxylase as a possible mediator of seizure-induced changes in genomic expression in rat hippocampus. J Neurosci 6:3430–3435
Bayer SA (1983) [3H]thymidine radiographic studies of neurogenesis in the rat olfactory bulb. Exp Brain Res 50:329–340
Bayer SA (1985) The development of the central nervous system. In: Wiggins RC, McCandless DW, Enna SJ (eds) Developmental Neurochemistry. University of Texas Press, pp 8–46
Bell JM, Withmore WL, Slotkin TA (1986) Effects of alpha-difluoromethylornithine, a specific irreversible inhibitor of ornithine decarboxylase, on nucleic acid and proteins in developing rat brain: critical perinatal periods for regional selectivity. Neuroscience 17:399–407
Facchinetti F, Ciani E, Sparapani M, Barnabei O, Contestabile A (1994) Impaired neurogenesis by methylazoxymethanol in newborn rats results in transient reduction of ornithine decarboxylase and polyamines in the cerebellum but not in the olfactory bulbs. Int J Dev Neurosci 12:19–24
Fonnum F (1975) A rapid radiochemical method for the determination of choline acetyltransferase. J Neurochem 24:407–409
Fonnum F, Grofova I, Rinvik E, Storm-Mathiesen J, Walberg F (1974) Origin and distribution of glutamate decarboxylase in the substantia nigra of the cat. Brain Res 71:77–92
Fujita K, Murakami U, Hayashi S (1982) A macromolecular inhibitor of the antizyme to ornithine decarboxylase. Biochem J 240:647–652
Gilad GM, Gilad VH (1980) Histochemical localization of ornithine decarboxylase with a labeled suicide enzyme inhibitor. Biochem Biophys Res Commun 96:1312–1316
Heby O (1981) Role of the polyamines in the control of cell proliferation and differentiation. Differentiation 19:1–20
Laitinen PH, Huhtinen R, Hietala OA, Pajunen AEI (1985) Ornithine decarboxylase activity in brain regulated by a specific macromolecule, the antizyme. J Neurochem 44:1885–1891
Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265–275
Morris G, Nadler JV, Slotkin TA (1986) Autoradiographic localization of ornithine decarboxylase in cerebellar cortex of the developing rat with 3 H alpha-difluoromethylornithine. Neuroscience 17:183–188
Murakami Y, Nisbiyama M, Hayashi S (1989) Involvement of antizyme in stabilization of ornithine decarboxylase caused by inhibitors of polyamine synthesis. Eur J Biochem 180:181–184
Onoue H, Matsufuji S, Nishiyama M, Murakami Y, Hayashi S (1988) Changes in ornithine decarboxylase and antizyme activities in developing mouse brain. Biochem J 250:797–803
Paschen W, Schmidt-Kastner R, Djuricic B, Meese C, Linn F, Hossmann KA (1987) Polyamine changes in reversible cerebral ischemia. J Neurochem 49:35–37
Paschen W, Röhn G, Meese CO, Djuricic B, Schmidt-Kastner R (1988) Polyamine metabolism in reversible cerebral ischemia: effect of alpha-difluoromethylornithine. Brain Res 453:9–16
Patel AJ, Hunt A, Tahourdin CSM (1983) Regional development of glutamine synthetase activity in rat brain and its association with the differentiation of astrocytes. Dev Brain Res 8:31–37
Prohaska JR, Clarck D, Wells WW (1973) Improved rapidity and precision in the determination of 2′,3′-cyclic-3′-phosphohydrolase. Anal Biochem 56:275–282
Sauer D, Martin P, Allegrini PR, Bernasconi R, Amacker H, Fagg GE (1992) Differing effects of α-difluoromethylornithine and CGP 40116 on polyamine levels and infarct volume in a rat model of focal cerebral ischaemia. Neurosci Lett 141:131–135
Slevin JT, Johnston MV, Biziere K, Coyle JT (1982) Methylazoxymethanol acetate ablation of mouse cerebellar granule cells: effects on synaptic neurochemistry Dev Neurosci 5:3–12
Slotkin TA, Bartolomé J (1986) Role of ornithine decarboxylase and the polyamines in nervous system development: a review. Brain Res Bull 17:307–320
Slotkin TA, Scidler FJ, Trepanier PA, Whitmore WL, Lerea L, Barnes GA, Weigel SJ, Bartolomé J (1982) Ornithine decarboxylase and polyamines in tissues of the neonatal rat: effects of alpha-difluoromethylornithine, a specific irreversible inhibitor of ornithine decarboxylase. J Pharmacol Exp Ther 222:741–745
Tabor CW, Tabor H (1984) Polyamines. Annu Rev Biochem 53:749–790
Virgili M, Barnabei O, Contestabile A (1990) Regional maturation of neurotransmitter-related and glial markers during postnatal development in the rat. Int J Dev Neurosci 8:159–166
Virgili M, Saverino O, Vaccari M, Barnabei O, Contestabile A (1991) Temporal, regional and cellular selectivity of neonatal alteration of the thyroid state on neurochemical maturation in the rat. Exp Brain Res 83:555–561
About this article
Cite this article
Sparapani, M., Virgili, M., Caprini, M. et al. Effects of gestational or neonatal treatment with alpha-difluoromethylornithine on ornithine decarboxylase and polyamines in developing rat brain and on adult rat neurochemistry. Exp Brain Res 108, 433–440 (1996). https://doi.org/10.1007/BF00227266
- Ornithine decarboxylase
- Brain development